Johnson & Johnson Inc in Beauty and Personal Care (World)

Johnson & Johnson Inc (J&J) is a healthcare company, which gives its BPC portfolio a pharmaceutical edge, in theory a competitive advantage in a market marked by rising consumer scrutiny for function, safety and credibility. However, the bulk of its offer is mass market, exposing it to price pressure and lukewarm prospects in the increasingly premium-aligned Western markets. J&J needs to exploit its strong brand equity to raise price points in areas such as baby care to remain competitive.

Euromonitor Internationals Johnson & Johnson Inc in Beauty and Personal Care (World) Company Profile offers detailed strategic analysis of the companys business, examining its performance in Beauty and Personal Care industry. The report examines company shares by region and sector, product developments, market and distribution strategies, challenges from the competition and future prospects. Use it to understand opportunities and threats facing the business and the factors driving success.

Product coverage: Baby and Child-specific Products, Bath and Shower, Colour Cosmetics, Deodorants, Depilatories, Fragrances, Hair Care, Mass Beauty and Personal Care, Mens Grooming, Oral Care, Oral Care Excl Power Toothbrushes, Premium Beauty and Personal Care, Sets/Kits, Skin Care, Sun Care.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Beauty and Personal Care market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the markets major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


Johnson & Johnson Inc in Beauty and Personal Care (World)
Euromonitor International
July 2017
Scope of the Report
Strategic Evaluation
Competitive Positioning
Market Assessment
Geographic and Category Opportunities
Brand Strategy
Operations
Recommendations

2020 Johnson & Johnson Performance, Capabilities, Goals and Strategies

This report is part of the Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.The report provides significant competitor information, analysis and insight critical to the development

USD 950 View Report

Anti-Infective Drugs Global Market Opportunities And Strategies To 2022 Including: By Product Type: Antibiotics, Antivirals, Antifungals, Others Covering: Gilead Sciences, GlaxoSmithKline, Merck & Co, Teva Pharmaceutical Industries Ltd., Johnson & Johnson

Anti-Infective Drugs Global Market Opportunities And Strategies To 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global anti-infective drugs market.Reasons to

USD 4000 View Report

2020 Johnson & Johnson Performance, Capabilities, Goals and Strategies

This report is part of the Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.The report provides significant competitor information, analysis and insight critical to the development

USD 950 View Report

Anti-Infective Drugs Global Market Opportunities And Strategies To 2022 Including: By Product Type: Antibiotics, Antivirals, Antifungals, Others Covering: Gilead Sciences, GlaxoSmithKline, Merck & Co, Teva Pharmaceutical Industries Ltd., Johnson & Johnson

Anti-Infective Drugs Global Market Opportunities And Strategies To 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global anti-infective drugs market.Reasons to

USD 4000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available